- Home
- XTNT vs PFX Comparison
XTNT vs PFX Comparison
Compare XTNT & PFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- PFX
- Stock Information
- Founded
- XTNT N/A
- PFX 2010
- Country
- XTNT United States
- PFX United States
- Employees
- XTNT N/A
- PFX N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- PFX Finance: Consumer Services
- Sector
- XTNT Health Care
- PFX Finance
- Exchange
- XTNT Nasdaq
- PFX Nasdaq
- Market Cap
- XTNT 82.1M
- PFX 96.4M
- IPO Year
- XTNT N/A
- PFX N/A
- Fundamental
- Price
- XTNT $0.64
- PFX $47.95
- Analyst Decision
- XTNT
- PFX
- Analyst Count
- XTNT 0
- PFX 0
- Target Price
- XTNT N/A
- PFX N/A
- AVG Volume (30 Days)
- XTNT 60.3K
- PFX 929.0
- Earning Date
- XTNT 11-11-2025
- PFX 08-06-2025
- Dividend Yield
- XTNT N/A
- PFX 2.95%
- EPS Growth
- XTNT N/A
- PFX N/A
- EPS
- XTNT N/A
- PFX 3.06
- Revenue
- XTNT $127,766,000.00
- PFX $23,958,590.00
- Revenue This Year
- XTNT $13.03
- PFX $10.24
- Revenue Next Year
- XTNT N/A
- PFX N/A
- P/E Ratio
- XTNT N/A
- PFX $15.86
- Revenue Growth
- XTNT 15.16
- PFX 7.47
- 52 Week Low
- XTNT $0.33
- PFX $44.56
- 52 Week High
- XTNT $0.78
- PFX $57.40
- Technical
- Relative Strength Index (RSI)
- XTNT 54.18
- PFX 38.58
- Support Level
- XTNT $0.59
- PFX $47.84
- Resistance Level
- XTNT $0.65
- PFX $48.54
- Average True Range (ATR)
- XTNT 0.04
- PFX 0.23
- MACD
- XTNT 0.00
- PFX -0.06
- Stochastic Oscillator
- XTNT 61.13
- PFX 8.52
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
About PFX PhenixFIN Corporation
PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.